Cargando…
Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
BACKGROUND: Anhedonia is a trans-diagnostic symptom in schizophrenia and MDD. Our recent work indicated that increased plasma level of complement factor H (CFH) is associated with anhedonia in major depressive disorder. This study hypothesized that CFH is likely to be a biomarker of anhedonia in sch...
Autores principales: | Zhang, Yi, Tang, Wei, Wang, Weiping, Xu, Feikang, Lu, Weihong, Zhang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372489/ https://www.ncbi.nlm.nih.gov/pubmed/37520223 http://dx.doi.org/10.3389/fpsyt.2023.1146714 |
Ejemplares similares
-
Association of Cognitive Impairment With Anhedonia in Patients With Schizophrenia
por: Yu, Lingfang, et al.
Publicado: (2021) -
Chemosensory Anhedonia in Patients With Schizophrenia and Individuals With Schizotypy: A Questionnaire Study
por: Li, Zi-lin, et al.
Publicado: (2020) -
Preliminary evidence that fatigue contributes to anhedonia in stable individuals diagnosed with schizophrenia
por: Laraki, Yasmine, et al.
Publicado: (2023) -
Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
por: An, Huimei, et al.
Publicado: (2022) -
Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
por: Fitzgerald, Ita, et al.
Publicado: (2021)